by Primrose Bio | Mar 30, 2026 | Events
Primrose Bio was proud to be part of World Vaccine Congress Washington, March 30–April 2, 2026. We were pleased to engage across the program: Our partner, Serum Institute of India Pvt. Ltd., was represented by Rakesh Lothe, who presented on multivalent conjugate... 
by Primrose Bio | Mar 20, 2026 | Scientific Posters
ABSTRACT: Peptide therapeutics are a fast-growing class of medicines, but traditional solid phase peptide synthesis (SPPS) has limitations in cost, scalability, and environmental impact. Pfenex Expression Technology® (Pfenex) provides an alternative by using a... 
by Primrose Bio | Mar 16, 2026 | Events
Our Associate Director of Analytical Development, Christopher Warner, PhD, presented a scientific poster at the 5th Annual Novel Conjugates Summit in Boston (March 9–11). The poster highlighted an approach to ncAA-enabled site-specific conjugation without sacrificing... 
by Primrose Bio | Mar 8, 2026 | Events
Our Senior Vice President of Process and Analytical Development, Jeff Allen, PhD, presented a scientific poster at BioProcess International US West in San Diego (March 9–11). Showcased how Pfenex Expression Technology® is advancing scalable, high-yield recombinant... 
by Primrose Bio | Jan 20, 2026 | Scientific Posters
ABSTRACT: A platform-based approach leveraging the Pfenex Expression Technology® was developed for implementing screening through lead optimization of novel ADCs As an example of the workflow, an Anti-GPCR VHH therapeutic candidate modified to include a single ncAA...